How are the deal terms structured, and how will ownership change?
- Marvell has signed a definitive agreement to acquire Lumentum in an all-stock transaction; each Lumentum share will be exchanged for 4.5 Marvell shares. The deal implies an enterprise value of about $115 billion, equivalent to $1,132 per Lumentum share and an implied premium of about 24% to its market capitalization on 28 October.
- After closing, Marvell’s existing shareholders are expected to own about 67% of the combined company, with Lumentum shareholders owning about 33%. Based on Marvell’s then-outstanding share count of about 877 million, the deal would require issuing about 405 million shares, increasing the share count by about 46%.
What does the combined product portfolio add?
- Marvell’s electrical and optical interconnect technologies will be combined with Lumentum’s lasers and optical transceivers to create a more comprehensive connectivity product portfolio for the networking needs of next-generation AI infrastructure.
- Lumentum’s advanced indium phosphide (InP) manufacturing capabilities offer another point of complementarity: the companies expect this to accelerate the development of next-generation optical technologies. The combined addressable market is expected to expand to $550 billion by 2030, which the report attributes to stronger capabilities to serve the scale-up and scale-in markets; this is market opportunity, not a revenue forecast.
How will synergies translate into profits, and when will the deal close?
- Management has identified more than $1 billion in annual cost synergies, primarily from cost of sales. The company expects the deal to be accretive to non-GAAP earnings per share in the first year after closing and to improve long-term revenue growth as well as non-GAAP gross and operating margins.
- The deal is expected to close in the first half of 2028, subject to approvals. Therefore, the expected synergies will feed into operating results only after closing and subsequent integration.
What are markets concerned about, and how has the stock price reacted?
- After news of the deal emerged, debate focused on the scale of the financing and equity dilution: Marvell had a cash balance of $3.9 billion at the end of the second quarter of FY27, while Lumentum’s market capitalization on 28 October was about $83 billion. The definitive agreement provides for all-stock payment, making the approximately 46% increase in share count the deal’s more direct impact on Marvell shareholders.
- As of the report’s publication, Marvell shares had fallen about 22% since news of the deal emerged. At 11:36 Eastern Time on the report date, Marvell was down a further 6.9%, while the Nasdaq was down 4.2%.